Deanne Miller
Chief Operating Officer en IMMUTEP LIMITED .
Fortuna: 809 998 $ al 31/03/2024
Perfil
Deanne Miller is currently the Co-Managing Director at Immutep GmbH and the COO, Secretary & General Counsel at Immutep Ltd.
She is also a Member of The Law Society of New South Wales.
Previously, she worked as an Associate Director at Westpac Banking Corp., a Manager-Legal & Compliance at Macquarie Group Ltd., and a Legal Counsel at RBC Investor Services Trust (Australia).
Ms. Miller completed her undergraduate and graduate degrees at The University of Sydney.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
IMMUTEP LTD
0.27% | 22/08/2023 | 3 267 305 ( 0.27% ) | 809 998 $ | 31/03/2024 |
Cargos activos de Deanne Miller
| Empresas | Cargo | Inicio |
|---|---|---|
| IMMUTEP LIMITED | Chief Operating Officer | 01/11/2016 |
| The Law Society of New South Wales | Corporate Officer/Principal | - |
Immutep GmbH
 Immutep GmbH BiotechnologyHealth Technology Part of Immutep Ltd., Immutep GmbH develops novel immunotherapy treatments for cancer and autoimmune disease. The private company is based in Leipzig, Germany. The CEOs of the German company are - Kaufmann, Marc Voigt, Deanne Miller. | Chief Executive Officer | - |
Antiguos cargos conocidos de Deanne Miller.
| Empresas | Cargo | Fin |
|---|---|---|
| MACQUARIE GROUP LIMITED | Compliance Officer | - |
| RBC Investor Services Trust (Australia) | General Counsel | - |
| WESTPAC BANKING CORPORATION | Corporate Officer/Principal | - |
Formación de Deanne Miller.
| The University of Sydney | Graduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| WESTPAC BANKING CORPORATION | Finance |
| IMMUTEP LIMITED | Health Technology |
| MACQUARIE GROUP LIMITED | Finance |
| Empresas privadas | 3 |
|---|---|
| The Law Society of New South Wales | |
| RBC Investor Services Trust (Australia) | Finance |
Immutep GmbH
Immutep GmbH BiotechnologyHealth Technology Part of Immutep Ltd., Immutep GmbH develops novel immunotherapy treatments for cancer and autoimmune disease. The private company is based in Leipzig, Germany. The CEOs of the German company are - Kaufmann, Marc Voigt, Deanne Miller. | Health Technology |
- Bolsa de valores
- Insiders
- Deanne Miller
